BMS-986449
Selleck Chemicals
SKU:E6404-1MG
Couldn't load pickup availability

BMS-986449 is a modulator linked to Protein Degradation / Proteasome and related pathway-oriented research. In practice, this places the compound in experiments that measure ubiquitin-dependent turnover, proteostasis, and targeted protein degradation in protein homeostasis models.
The pathway annotation connects BMS-986449 to Protein Degradation / Proteasome, supporting experiments that monitor ubiquitin-dependent turnover, proteostasis, and targeted protein degradation across biochemical, cellular, or phenotypic assay formats. This context is compatible with degradation, proteasome, and protein-turnover assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In protein homeostasis models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Pathway perturbation studies connected to Protein Degradation / Proteasome
- Context-dependent response profiling and mechanism comparison
- Phenotypic profiling in protein homeostasis models
- Combination studies with orthogonal perturbagens
Overall, BMS-986449 is well suited to pathway-oriented studies that need a defined compound input for Protein Degradation / Proteasome readouts in protein homeostasis models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Pathways:
- Protein Degradation / Proteasome
- Research Area:
- Protein Homeostasis
- Molecular Weight:
- 396.41
- Formula:
- C₂₁H₂₁FN₄O₃
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.